24 HOUR WU ALLOCATION
| Research | Percent |
|---|---|
|
CANCER |
71.94% |
|
ALZHEIMERS |
28.06% |
7 DAY WU ALLOCATION
| Research | Percent |
|---|---|
|
ALZHEIMERS |
39.14% |
|
CANCER |
31.93% |
|
ENZYME DYNAMICS |
12.61% |
|
PEPTIDOMIMETIC CD40L BINDING |
11.16% |
|
ATSTP10 TRANSPORT SIMULATION |
3.72% |
|
ATSTP10 SUCROSE TRANSPORT |
1.44% |
12 WEEK WU ALLOCATION
| Research | Percent |
|---|---|
|
ENZYME DYNAMICS |
27.31% |
|
CANCER |
25.27% |
|
PEPTIDOMIMETIC CD40L BINDING |
19.4% |
|
ALZHEIMERS |
11.17% |
|
ATGPA1 POST TRANSLATIONAL MODIFICATION DYNAMICS |
7.46% |
|
ATGPA1 POST TRANSLATIONAL MODIFICATIONS |
6.49% |
|
ATSTP10 SUCROSE TRANSPORT |
1.4% |
|
ATSTP10 TRANSPORT SIMULATION |
.87% |
|
MEMBRANE TRANSPORT |
.38% |
|
NIPAH VIRUS DECOY PROTEIN DYNAMICS |
.2% |
|
SUCROSE TRANSPORTER ATSUC1 |
.06% |